Cargando…
A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab
Since the beginning of the pandemic, numerous national and international clinical trials have been conducted with a large number of drugs. Many of them are intended for the treatment of other pathologies; however, despite the great effort made, no specific drug is available for the treatment of the...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784859/ https://www.ncbi.nlm.nih.gov/pubmed/35072887 http://dx.doi.org/10.1007/s12325-022-02042-3 |